Literature DB >> 29096030

Tacrolimus: A Review of Laboratory Detection Methods and Indications for Use.

Derick A Kalt1,2.   

Abstract

Tacrolimus (Tac) is an immunosuppressive drug that is used in preventing organ and tissue rejection in patients after transplantation. Tac administration requires frequent and diligent monitoring by physicians to ensure proper dosage and to limit the potential for harmful adverse effects, which can include renal damage, neurotoxicity, and other serious adverse events. Tac is a calcineurin inhibitor, which suppresses the function of T-cells. Its success as an immunosuppressive agent has been well documented in preventing graft-vs-host disease in several types of organ transplants. This literature review will discuss Tac metabolism and its role in preventing tissue and organ transplant rejection. A variety of detection techniques used in the clinical laboratory, including dried-blood-spot analysis, liquid chromatography-tandem mass spectrometry, and immunoassay also will be discussed. © American Society for Clinical Pathology, 2017. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  drug monitoring; graft-vs-host disease; immunoassay; organ transplantation; tacrolimus; tandem mass spectrometry

Mesh:

Substances:

Year:  2017        PMID: 29096030     DOI: 10.1093/labmed/lmx056

Source DB:  PubMed          Journal:  Lab Med        ISSN: 0007-5027


  7 in total

1.  Inhibition of the cyclophilin A-CD147 interaction attenuates right ventricular injury and dysfunction after acute pulmonary embolism in rats.

Authors:  Guangdong Lu; Zhenyu Jia; Qingquan Zu; Jinxing Zhang; Linbo Zhao; Haibin Shi
Journal:  J Biol Chem       Date:  2018-06-18       Impact factor: 5.157

2.  Variation in Tacrolimus Trough Concentrations in Liver Transplant Patients Undergoing Endoscopic Retrograde Cholangiopancreatography: A Retrospective, Observational Study.

Authors:  Rongrong Wang; Weili Wang; Kuifen Ma; Xin Duan; Fangfang Wang; Mingzhu Huang; Wei Zhang; Tingbo Liang
Journal:  Front Pharmacol       Date:  2020-08-19       Impact factor: 5.810

Review 3.  [Adverse reactions of drugs specifically used for treatment of SARS-CoV-2 infection].

Authors:  Valeria Herrera-Lasso Regás; María Teresa Dordal Culla; Ramón Lleonart Bellfill
Journal:  Med Clin (Barc)       Date:  2020-07-09       Impact factor: 1.725

4.  Network pharmacology-based analysis of the role of tacrolimus in liver transplantation.

Authors:  Lijian Chen; Yuming Peng; Chunyi Ji; Miaoxian Yuan; Qiang Yin
Journal:  Saudi J Biol Sci       Date:  2021-01-13       Impact factor: 4.219

5.  Validation of a Capillary Dry Blood Sample MITRA-Based Assay for the Quantitative Determination of Systemic Tacrolimus Concentrations in Transplant Recipients.

Authors:  Nasrullah Undre; Ian Dawson; Varuna Aluvihare; Nassim Kamar; Faouzi Saliba; Nicholas Torpey; Swapneel Anaokar; Gbenga Kazeem; Imran Hussain
Journal:  Ther Drug Monit       Date:  2021-06-01       Impact factor: 3.681

6.  Quantitation of Tacrolimus in Human Whole Blood Samples Using the MITRA Microsampling Device.

Authors:  Nasrullah Undre; Imran Hussain; John Meijer; Johannes Stanta; Gordon Swan; Ian Dawson
Journal:  Ther Drug Monit       Date:  2021-06-01       Impact factor: 3.681

Review 7.  T Lymphocytes: A Promising Immunotherapeutic Target for Pancreatitis and Pancreatic Cancer?

Authors:  Qi Zhou; Xufeng Tao; Shilin Xia; Fangyue Guo; Chen Pan; Hong Xiang; Dong Shang
Journal:  Front Oncol       Date:  2020-03-24       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.